EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update

Abstract

On the bases of evidence and Delphe method developed recommendations for therapy of rheumatoid arthritis with emphasis of application of conventional and synthetic DMARDs and biologic DMARDs including biosimilar drugs.

Keywords

• rheumatoid arthritis
• biologic therapy
• EULAR guidelines